Evidence mapPaperPMID 40344668Full record

ArticleJMIR formative research2025

Cocreating the Visualization of Digital Mobility Outcomes: Delphi-Type Process With Patients.

Jack Lumsdon, Cameron Wilson, Lisa Alcock, Clemens Becker, Francesco Benvenuti, Tecla Bonci, Koen van den Brande, Gavin Brittain, Philip Brown, Ellen Buckley and 25 more

Abstract read
In one paragraph

Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Jack LumsdonPopulation Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0009-0001-8985-0209
Cameron WilsonSchool of Clinical Medicine, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-2047-2817
Lisa AlcockTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0002-8364-9803
Clemens BeckerRobert Bosch Society for Medical Research, Stuttgart, Germany.ORCID 0000-0003-1624-8353
Francesco BenvenutiMobilise-D Patient and Public Advisory Group, Newcastle Upon Tyne, United Kingdom.ORCID 0009-0002-8944-5147
Tecla BonciSchool of Mechanical, Aerospace and Civil Engineering, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-8255-4730
Koen van den BrandeMobilise-D Patient and Public Advisory Group, Newcastle Upon Tyne, United Kingdom.
Gavin BrittainDepartment of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.ORCID 0000-0002-9903-7203
Philip BrownThe Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.ORCID 0009-0004-6425-0452
Ellen BuckleyInsigneo Institute for Silico Medicine, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-0968-6286
Marco CarusoDepartment of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy.ORCID 0000-0002-1529-8095
Brian CaulfieldInsights Centre Data Analytics, University College Dublin, Dublin, Ireland.ORCID 0000-0003-0290-9587
Andrea CereattiDepartment of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy.ORCID 0000-0002-7276-5382
Laura Delgado-OrtizBarcelona Institute for Global Health, Barcelona, Spain.ORCID 0000-0003-0311-7661
Silvia Del DinTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0003-1154-4751
Jordi EversMcRoberts BV, The Hague, The Netherlands.ORCID 0000-0002-7970-8575
Judith Garcia-AymerichBarcelona Institute for Global Health, Barcelona, Spain.ORCID 0000-0002-7097-4586
Heiko GaßnerDepartment of Molecular Neurology, University Hospital Erlangen, Erlangen, Germany.ORCID 0000-0003-2037-9460
Tova Gur AriehMobilise-D Patient and Public Advisory Group, Newcastle Upon Tyne, United Kingdom.
Clint HansenDepartment of Neurology, University Medical Center Schleswig-Holstein Campus, Kiel, Germany.ORCID 0000-0003-4813-3868
Jeffrey M HausdorffSagol School of Neuroscience and Department of Physical Therapy, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-1608-0776
Hugo HidenSchool of Computer Science, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0003-0843-5124
Emily HumeDepartment of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0003-0462-2395
Cameron KirkTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0003-2508-5816
Walter MaetzlerDepartment of Neurology, University Medical Center Schleswig-Holstein Campus, Kiel, Germany.ORCID 0000-0002-5945-4694
Dimitrios MegaritisTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0001-6786-4346
Lynn RochesterTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0001-5774-9272
Kirsty ScottTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0009-0007-7931-1424
Basil SharrackDepartment of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.ORCID 0009-0000-3594-7534
Norman SuttonMobilise-D Patient and Public Advisory Group, Newcastle Upon Tyne, United Kingdom.
Beatrix VereijkenDepartment of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0002-2231-8138
Ioannis VogiatzisDepartment of Sport, Exercise and Rehabilitation, Northumbria University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0003-4830-7207
Alison YarnallTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0002-3126-9163
Alison KeoghInsights Centre Data Analytics, University College Dublin, Dublin, Ireland.ORCID 0000-0001-5917-6308
Alma CantuSchool of Computer Science, Newcastle University, Newcastle Upon Tyne, United Kingdom.ORCID 0000-0001-6081-2439

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent technological advances in wearable devices offer new potential for measuring mobility in real-world contexts. Mobilise-D has validated digital mobility outcomes to provide novel outcomes and end points in clinical research of 4 different long-term health conditions (Parkinson disease, multiple sclerosis, chronic obstructive pulmonary disease, and proximal femoral fracture). These outcomes also provide unique information that is important to patients; however, there is limited literature that explores the optimal methods to achieve this, such as the best way to visualize patients' data.

objectiveThis study aimed to identify meaningful outcomes for each condition and how to best visualize them from the perspective of end users.

methodsUsing a Delphi-type protocol with patients as subject matter experts, we gathered iterative feedback on the cocreation of visualizations through 3 rounds of questionnaires. An open-ended questionnaire was used in round 1 to understand what aspects of mobility were most influenced by their health condition. These responses were mapped onto relevant digital mobility outcomes and walking experiences and then prioritized for visualization. Using patient responses, we worked alongside researchers, clinicians, and a patient advisory group to develop visualizations that depicted a week of mobility data. During rounds 2 and 3, participants rated usefulness and ease of understanding on a 5-point Likert scale and provided unstructured feedback in comment boxes for each visualization. Visualizations were refined using the feedback from round 2 before receiving further feedback in round 3.

resultsParticipation varied across rounds 1 to 3 (n=48, n=79, and n=78, respectively). Round 1 identified important outcomes and contexts for each health condition, such as walking speed and stride length for people with Parkinson disease or multiple sclerosis and number of steps for people with chronic obstructive pulmonary disease or proximal femoral fracture. The consensus was not reached for any visualization reviewed in round 2 or 3. Feedback was generally positive, and some participants reported that they were able to understand the visualization and interpret what the visualization represented.

conclusionsThrough the feedback provided and existing data visualization principles, we developed recommendations for future visualizations of mobility- and health-related data. Visualizations should be readable by ensuring that large and clear fonts are used and should be friendly for people with vision impairments, such as color blindness. Patients have a strong understanding of their own condition and its variability; hence, adding additional factors into visualizations is recommended to better reflect the nuances of a condition. Ensuring that outcomes and visualizations are meaningful requires close collaboration with patients throughout the development process.

Indexed as

WalkingWearable Electronic DevicesAdultAgedDelphi TechniqueFemaleHumansMaleMiddle AgedMultiple SclerosisParkinson DiseasePulmonary Disease, Chronic ObstructiveSurveys and Questionnairescocreationdata visualizationdigital mobility outcomesmobilitywearable devices

Identifiers

PMID40344668
PMCPMC12102624

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.